Category Archives: Indian Patent Law

Delhi HC issues notice on Prof. Shamnad Basheer’s PIL on patent working norms

Source: Live Law 2 Sep 2015 A Delhi High Court Bench comprising Chief Justice G. Rohini and Justice Jayant Nath hasreportedly sought a reply from the Government on Prof. Shamnad Basheer’s PIL regarding patent working norms. The Government had been … Continue reading

Posted in Compulsory Licensing, Indian Patent Law, Patent revocation, Patent working | Leave a comment

HC notice to govt over MNCs’ patent disclosure

Source: Times of India 2 Sep 2015 MUMBAI: In a development that could have major ramifications on intellectual property cases in pharmaceutical and technology sectors, the Delhi high court issued a notice to the government on Tuesday in a PIL … Continue reading

Posted in Compulsory Licensing, Indian Patent Law, Patent revocation, Patent working | Leave a comment

High Court rejects AstraZeneca’s diabetes drug plea

Source: The Economic Times MUMBAI: The Delhi High Court has dismissed AstraZeneca’s plea to block Hyderabad based Lee Pharma from making copies of its anti-diabetes drug Onglyza and left it for the patent office to decide whether to grant a compulsory … Continue reading

Posted in Compulsory Licensing, Indian Patent Law, TRIPS flexibilities | Leave a comment

AstraZeneca not importing enough of diabetes drug: Lee Pharma

Source: Business Standard 8 July 2015 The move was a sign of the evolution of compulsory licensing in India, say experts Hyderabad-based Lee Pharma, which applied for a compulsory licence of international drug major AstraZeneca’s patented diabetes medicine Saxagliptin last month, … Continue reading

Posted in Compulsory Licensing, Indian Patent Law | Leave a comment

Mixed signals not a good sign for IPR

Source : Business Today, April 29, 2015 On April 23, while speaking at a three-day Global Exhibition of Services in New Delhi, Prime Minister Narendra Modi made a statement that intrigued many in the Indian pharmaceutical industry. Though he spoke … Continue reading

Posted in Indian Patent Law, Make in India Campaign, Sec 3 (d), TRIPS, US pressure on India | Leave a comment

India again on US IPR priority watch list; Govt disappointed, but not worried

Source : The Hindu, 1 May, 2015 India is disappointed at being featured yet again in the US Priority Watch List of weak IPR countries. But it is not worried. A senior Commerce & Industry Ministry official told BusinessLine that … Continue reading

Posted in Indian Patent Law, TRIPS, TRIPS plus, US pressure on India, USTR 301 report | Leave a comment

India remains on USTR priority watch list

Source : Express Pharma, 4 May, 2015 But no OCR this year … as yet India remains on the US Trade Representative’s Priority Watch list of its annual Special 301 review. Unlike last year, the USTR is not announcing an … Continue reading

Posted in Indian Patent Law, Out of Cycle Review (OCR), TRIPS, TRIPS plus, US pressure on India, USTR 301 report | Leave a comment